EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 33 (2026) Parasite, 33 (2026) 2 References
Open Access
Issue
Parasite
Volume 33, 2026
Article Number 2
Number of page(s) 6
DOI https://doi.org/10.1051/parasite/2026001
Published online 22 January 2026
  1. Becskei C, Bock FD, Illambas J, Cherni JA, Fourie JJ, Lane M, Mahabir SP, Six RH. 2016. Efficacy and safety of a novel oral isoxazoline, sarolaner (SimparicaTM), for the treatment of sarcoptic mange in dogs. Veterinary Parasitology 222, 56–61. [Google Scholar]
  2. Becskei C, Liebenberg J, Fernandes T, Borowski S, D’Hanis L, Mahabir SP. 2023. Efficacy of a chewable tablet containing sarolaner, moxidectin, and pyrantel (Simparica Trio®) in the treatment of sarcoptic mange caused by Sarcoptes scabiei mite infestations in dogs. Parasites & Vectors 16, 441. [Google Scholar]
  3. Bernigaud C, Fang F, Fischer K, Lespine A, Aho LS, Mullins AJ, Tecle B, Kelly A, Sutra J-F, Moreau F, Lilin T, Beugnet F, Botterel F, Chosidow O, Guillot J. 2018. Efficacy and pharmacokinetics evaluation of a single oral dose of afoxolaner against Sarcoptes scabiei in the porcine scabies model for human infestation. Antimicrobial Agents and Chemotherapy, 62, e02334-17. [Google Scholar]
  4. Beugnet F, Halos L, Guillot J. 2018. Textbook of clinical parasitology in dogs and cats. Zaragoza, Spain: Grupo Asis Biomedia. [Google Scholar]
  5. Beugnet F, de Vos C, Liebenberg J, Halos L, Larsen D, Fourie J. 2016. Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei. Parasite, 23, 26. [Google Scholar]
  6. Chiummo R, Petersen I, Plehn C, Zschiesche E, Roepke R, Thomas E. 2020. Efficacy of orally and topically administered fluralaner (Bravecto®) for treatment of client-owned dogs with sarcoptic mange under field conditions. Parasites & Vectors, 13, 524. [Google Scholar]
  7. Colombo M, Morelli S, Sacra M, Trezza G, Paoletti B, Traversa D, Cesare AD. 2022. An uncommon and severe clinical case of Sarcoptes scabiei infestation in a cat. Pathogens, 12, 62. [Google Scholar]
  8. Curtis CF. 2012. Canine sarcoptic mange (sarcoptic acariasis, canine scabies). Companion Animal, 17, 32–36. [Google Scholar]
  9. Feather L, Gough K, Flynn RJ, Elsheikha HM. 2010. A retrospective investigation into risk factors of sarcoptic mange in dogs. Parasitology Research, 107, 279–283. [Google Scholar]
  10. Fourie L, Heine J, Horak I. 2006. The efficacy of an imidacloprid/moxidectin combination against naturally acquired Sarcoptes scabiei infestations on dogs. Australian Veterinary Journal, 84, 17–21. [Google Scholar]
  11. Guaguère E, Beugnet F. 2008. Parasitic skin conditions, in A Practical Guide to Canine Dermatology, Guaguère E, Prélaud P, Craig M, Editors. Kalianxis: Paris. pp. 179–226. [Google Scholar]
  12. Hampel V, Knaus M, Schäfer J, Beugnet F, Rehbein S. 2018. Treatment of canine sarcoptic mange with afoxolaner (NexGard®) and afoxolaner plus milbemycin oxime (NexGard Spectra®) chewable tablets: efficacy under field conditions in Portugal and Germany. Parasite, 25, 63. [Google Scholar]
  13. Hyun J-E, Jang H-K, Hwang C-Y, Yeon S-C. 2019. Clinical efficacy of orally administered fluralaner for treatment of scabies in six free-ranging raccoon dogs (Nyctereutes procyonoides). Veterinary Dermatology, 30, 267-e81. [Google Scholar]
  14. Jacobs D, Fox M, Gibbons L, Hermosilla C. 2015. Principles of Veterinary Parasitology. NY: Wiley-Blackwell. p. 320. [Google Scholar]
  15. Krieger K, Heine J, Dumont P, Hellmann K. 2005. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study. Parasitology Research, 97, S81–S88. [Google Scholar]
  16. Miller W, Griffin C, Campbell K, Muller G. 2013. Muller and Kirk’s Small animal Dermatology (7th ed.). St Louis, Missouri: Elsevier, Mosby. p. 952. [Google Scholar]
  17. Moog F, Brun J, Bourdeau P, Cadiergues MC. 2021. Clinical, parasitological, and serological follow‐up of dogs with sarcoptic mange treated orally with lotilaner. Case Reports in Veterinary Medicine, 2021, 6639017. [Google Scholar]
  18. Moroni B, Rossi L, Bernigaud C, Guillot J. 2022. Zoonotic episodes of scabies: A global overview. Pathogens, 11, 213. [CrossRef] [PubMed] [Google Scholar]
  19. Mounsey KE, Walton SF. 2011. Scabies and other mite infections, in Oxford Textbook of Zoonoses, 2nd Ed., Palmer SR, Torgerson P, Brown DWG, Editors. Oxford University Press. p. 801–811. [Google Scholar]
  20. Romero C, Heredia R, Pineda J, Serrano JA, Mendoza GD, Trápala P, Cordero AM. 2016. Efficacy of fluralaner in 17 dogs with sarcoptic mange. Veterinary Dermatology, 27, 353-e88. [Google Scholar]
  21. Romero-Núñez C, Bautista-Gómez LG, Sheinberg G, Martín-Cordero A, Flores-Ortega A, Heredia-Cárdenas R. 2019. Efficacy of afoxolaner plus milbemycin oxime and afoxolaner alone as treatment for sarcoptic mange in naturally infested dogs. Canadian Journal of Veterinary Research, 84, 212–216. [Google Scholar]
  22. Shanks DJ, McTier TL, Behan S, Pengo G, Genchi C, Bowman DD, Holbert MS, Smith DG, Jernigan AD, Rowan TG. 2000. The efficacy of selamectin in the treatment of naturally acquired infestations of Sarcoptes scabiei on dogs. Veterinary Parasitology, 91, 269–281. [Google Scholar]
  23. Sharaf MS. 2024. Scabies: Immunopathogenesis and pathological changes. Parasitology Research, 123, 149. [Google Scholar]
  24. Six RH, Clemence RG, Thomas CA, Behan S, Boy MG, Watson P, Benchaoui HA, Clements PJM, Rowan TG, Jernigan AD. 2000. Efficacy and safety of selamectin against Sarcoptes scabiei on dogs and Otodectes cynotis on dogs and cats presented as veterinary patients. Veterinary Parasitology, 91, 291–309. [Google Scholar]
  25. Smith JS, Berger DJ, Hoff SE, Chelladurai JRJJ, Martin KA, Brewer MT. 2020. Afoxolaner as a treatment for a novel Sarcoptes scabiei infestation in a juvenile potbelly pig. Frontiers in Veterinary Science, 7, 473. [Google Scholar]
  26. Taenzler J, Liebenberg J, Roepke RKA, Frénais R, Heckeroth AR. 2016. Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs. Parasites & Vectors, 9, 392. [Google Scholar]
  27. Terada Y, Murayama N, Ikemura H, Morita T, Nagata M. 2010. Sarcoptes scabiei var. canis refractory to ivermectin treatment in two dogs. Veterinary Dermatology, 21, 608–612. [Google Scholar]
  28. Wagner R, Wendlberger U. 2000. Field efficacy of moxidectin in dogs and rabbits naturally infested with Sarcoptes spp., Demodex spp. Veterinary Parasitology, 93, 149–158. [Google Scholar]
  29. Wilkinson V, Takano K, Nichols D, Martin A, Holme R, Phalen D, Mounsey K, Charleston M, Kreiss A, Pye R, Browne E, Næsborg-Nielsen C, Richards SA, Carver S. 2021. Fluralaner as a novel treatment for sarcoptic mange in the bare-nosed wombat (Vombatus ursinus): Safety, pharmacokinetics, efficacy and practicable use. Parasites & Vectors, 14, 18. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.